The risk of ADLI was higher in cases with CpG island methylation level of CYP2E1 and CYP2D6 by 1.429 and 2.5 times, respectively, compared to those without CpG island methylation after anti-TB chemotherapy. This evidence concerns the gene CYP2D6 and tuberculosis.